Polymers,
Journal Year:
2025,
Volume and Issue:
17(3), P. 423 - 423
Published: Feb. 6, 2025
Transition-metal
ion
copper(II)
(Cu(II))
has
drawn
increasing
attention
as
a
small-molecular
cancer
theranostic
agent.
However,
delivering
sufficient
dosage
of
Cu(II)
to
the
tumor
site
and
integrating
multiple
imaging
modalities
achieve
precise
effective
theranostics
remains
critical
challenge.
Herein,
an
emerging
Cu(II)-based
nanocomposite
been
synthesized
for
targeted
computed
tomography
(CT)/magnetic
resonance
(MR)
dual-mode
chemodynamic
therapy
(CDT).
Briefly,
2-picolinic
acid
(PA-COOH),
polyethylene
glycol
(PEG)-linked
folic
(FA),
fluorescein
isothiocyanate
(FI)
were
sequentially
conjugated
with
polyethylenimine
(PEI.NH2)
then
in
situ
fabrication
gold
nanoparticles
(Au
NPs)
occurred
within
PEI.NH2
internal
cavity.
After
acetylation
terminal
amines
complexation,
nanocomposites
FA-Au/Cu(II)
PENPs
mean
diameter
2.87
nm
generated.
The
showed
favorable
stability
colloidal
dispersion,
sustainable
release
properties
pH-dependent
manner,
Fenton-like
catalytic
activity
specifically.
With
FA-mediated
targeting
pathway,
can
specifically
accumulate
cells
high
expression
FA
receptors.
Meanwhile,
complementary
CT/MR
vitro
vivo
be
afforded
by
based
on
excellent
X-ray
attenuation
Au
NPs
applicable
r1
relaxivity
(0.7378
mM−1s−1)
Cu(II).
Notably,
Cu(II)-mediated
CDT
mechanism
enables
elicit
generation
toxic
hydroxyl
radicals
(·OH),
depletion
glutathione
(GSH),
promotion
lipid
peroxidation
(LPO),
induction
cell
apoptosis
vitro,
further
demonstrates
remarkable
anti-tumor
efficacy
xenograft
model.
illustrated
capacity
towards
tumors,
this
paradigm
inspires
construction
advanced
nanoplatforms
incorporating
alternative
transition
metal
ions.
Environment International,
Journal Year:
2023,
Volume and Issue:
175, P. 107928 - 107928
Published: April 11, 2023
Pharmaceutical
residues
are
the
undecomposed
remains
from
drugs
used
in
medical
and
food
industries.
Due
to
their
potential
adverse
effects
on
human
health
natural
ecosystems,
they
of
increasing
worldwide
concern.
The
acute
detection
pharmaceutical
can
give
a
rapid
examination
quantity
then
prevent
them
further
contamination.
Herein,
this
study
summarizes
discusses
most
recent
porous
covalent-organic
frameworks
(COFs)
metal–organic
(MOFs)
for
electrochemical
various
residues.
review
first
introduces
brief
overview
drug
toxicity
its
living
organisms.
Subsequently,
different
materials
techniques
discussed
with
materials'
properties
applications.
Then
development
COFs
MOFs
has
been
addressed
structural
sensing
Further,
stability,
reusability,
sustainability
MOFs/COFs
reviewed
discussed.
Besides,
MOFs'
limits,
linear
ranges,
role
functionalities,
immobilized
nanoparticles
analyzed
Lastly,
summarized
[email
protected]
composite
as
sensors,
fabrication
strategies
enhance
potential,
current
challenges
area.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology,
Journal Year:
2024,
Volume and Issue:
16(1)
Published: Jan. 1, 2024
Abstract
Cancer
presents
a
formidable
challenge,
necessitating
innovative
therapies
that
maximize
effectiveness
while
minimizing
harm
to
healthy
tissues.
Nanotechnology
has
emerged
as
transformative
force
in
cancer
treatment,
particularly
through
nano‐enabled
photodynamic
therapy
(NE‐PDT),
which
leverages
precise
and
targeted
interventions.
NE‐PDT
capitalizes
on
photosensitizers
activated
by
light
generate
reactive
oxygen
species
(ROS)
initiate
apoptotic
pathways
cells.
Nanoparticle
enhancements
optimize
this
process,
improving
drug
delivery,
selectivity,
ROS
production
within
tumors.
This
review
dissects
NE‐PDT's
mechanistic
framework,
showcasing
its
potential
harness
apoptosis
potent
tool
therapy.
Furthermore,
the
explores
synergy
between
complementary
treatments
like
chemotherapy,
immunotherapy,
therapies,
highlighting
amplify
responses,
enhance
immune
recognition
of
cells,
inhibit
resistance
mechanisms.
Preclinical
clinical
advancements
demonstrate
efficacy
across
various
types.
Challenges
translating
into
practice
are
also
addressed,
emphasizing
need
for
optimizing
nanoparticle
design,
refining
dosimetry,
ensuring
long‐term
safety.
Ultimately,
represents
promising
approach
therapy,
utilizing
intricate
mechanisms
address
therapeutic
hurdles.
The
underscores
importance
understanding
interplay
nanoparticles,
generation,
pathways,
contributing
deeper
comprehension
biology
novel
strategies.
As
interdisciplinary
collaborations
continue
thrive,
offers
hope
effective
interventions,
where
manipulation
becomes
central
conquering
cancer.
article
is
categorized
under:
Therapeutic
Approaches
Drug
Discovery
>
Nanomedicine
Oncologic
Disease
Advanced Healthcare Materials,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 7, 2025
Abstract
Metal‐protein
hybrid
materials
represent
a
novel
class
of
functional
that
exhibit
exceptional
physicochemical
properties
and
tunable
structures,
rendering
them
remarkable
applications
in
diverse
fields,
including
engineering,
biocatalysis,
biosensing,
biomedicine.
The
design
development
multifunctional
biocompatible
metal‐protein
have
been
the
subject
extensive
research
key
aspiration
for
practical
clinical
settings.
This
review
provides
comprehensive
analysis
strategies,
intrinsic
properties,
biomedical
these
materials,
with
specific
emphasis
on
their
potential
cancer
therapy,
drug
vaccine
delivery,
antibacterial
treatments,
tissue
regeneration.
Through
rational
design,
stable
can
be
synthesized
using
straightforward
methods,
enabling
therapeutic,
immunomodulatory,
other
desired
functionalities.
Finally,
outlines
existing
limitations
challenges
associated
evaluates
translation,
providing
insights
into
implementation
within
applications.
World Journal of Hepatology,
Journal Year:
2023,
Volume and Issue:
15(4), P. 460 - 476
Published: April 20, 2023
Hepatocellular
carcinoma
(HCC)
is
the
most
prevalent
form
of
primary
liver
cancer,
accounting
for
75%-85%
cases.
Although
treatments
are
given
to
cure
early-stage
HCC,
up
50%-70%
individuals
may
experience
a
relapse
illness
in
after
5
years.
Research
on
fundamental
treatment
modalities
recurrent
HCC
moving
significantly
further.
The
precise
selection
therapy
strategies
with
established
survival
advantages
crucial
ensuring
better
outcomes.
These
aim
minimize
substantial
morbidity,
support
good
life
quality,
and
enhance
patients
HCC.
For
recurring
curative
treatment,
no
approved
therapeutic
regimen
currently
available.
A
recent
study
presented
novel
approaches,
like
immunotherapy
antiviral
medication,
improve
prognosis
apparent
lack
data
guide
clinical
treatment.
supporting
several
neoadjuvant
adjuvant
therapies
outlined
this
review.
We
also
discuss
potential
future
translational
investigations.